REQUEST A DEMO
Total
USD $0.00
Search more companies

Diagnostico y Terapeutica en Gastroenterologia y Hepatologia S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Diagnostico y Terapeutica en Gastroenterologia y Hepatologia S.A.S. Profile Updated: August 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Diagnostico y Terapeutica en Gastroenterologia y Hepatologia S.A.S. is a company based in Colombia, with its head office in Cartagena. It operates in the Diagnostic Imaging Centers industry. The company was established on March 16, 2013. 7 (2024) employees currently work for Diagnostico y Terapeutica en Gastroenterologia y Hepatologia S.A.S.. In its most recent financial highlights, the company reported a net sales revenue drop of 69.83% in 2023. Its’ total assets recorded a growth of 0.52%. The net profit margin of Diagnostico y Terapeutica en Gastroenterologia y Hepatologia S.A.S. decreased by 12.71% in 2023.

Headquarters
Cra 2A # 13-89 Local 2 Bocagrande
Cartagena; Bolivar;

Contact Details: Purchase the Diagnostico y Terapeutica en Gastroenterologia y Hepatologia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Diagnostico y Terapeutica en Gastroenterologia y Hepatologia S.A.S. report to view the information.
Outstanding Shares:
Purchase the Diagnostico y Terapeutica en Gastroenterologia y Hepatologia S.A.S. report to view the information.
Incorporation Date:
March 16, 2013
Key Executives
Company Performance
Financial values in the chart are available after Diagnostico y Terapeutica en Gastroenterologia y Hepatologia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-69.83%
Total operating revenue
-69.83%
Net Profit (Loss) for the Period
-86.53%
Total assets
0.52%
Total equity
-22.95%
Net Profit Margin
-12.71%
Return on Equity (ROE)
-62.43%
Quick Ratio
-0.5%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?